fluoxetine has been researched along with Adolescent Obesity in 2 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Child and adolescent obesity has increased globally, and can be associated with significant short- and long-term health consequences." | 2.53 | Drug interventions for the treatment of obesity in children and adolescents. ( Atkinson, G; Baur, L; Corpeleijn, E; Ells, LJ; Finer, N; Mead, E; Metzendorf, MI; O'Malley, C; Richter, B, 2016) |
| "It is well known that overnutrition, overweight, and obesity in children can modulate brain mechanisms of plasticity, monoaminergic systems, and mitochondrial function." | 1.91 | The immediate effect of overnutrition and fluoxetine treatment during the critical period of development on the hippocampus. ( da Silva, AI; de Andrade Silva, SC; de Lemos, MDT; Lagranha, CJ; Rodrigues, TO; Santos-Junior, OH; Silva, TL; Tavares, GA, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Andrade Silva, SC | 3 |
| de Lemos, MDT | 3 |
| Santos-Junior, OH | 3 |
| Rodrigues, TO | 3 |
| Silva, TL | 3 |
| Tavares, GA | 3 |
| da Silva, AI | 3 |
| Lagranha, CJ | 3 |
| Mead, E | 1 |
| Atkinson, G | 1 |
| Richter, B | 1 |
| Metzendorf, MI | 1 |
| Baur, L | 1 |
| Finer, N | 1 |
| Corpeleijn, E | 1 |
| O'Malley, C | 1 |
| Ells, LJ | 1 |
1 review available for fluoxetine and Adolescent Obesity
| Article | Year |
|---|---|
Drug interventions for the treatment of obesity in children and adolescents.
Topics: Adolescent; Anti-Obesity Agents; Body Mass Index; Child; Cyclobutanes; Fluoxetine; Humans; Lactones; | 2016 |
1 other study available for fluoxetine and Adolescent Obesity
| Article | Year |
|---|---|
The immediate effect of overnutrition and fluoxetine treatment during the critical period of development on the hippocampus.
Topics: Animals; Female; Fluoxetine; Hippocampus; Mitochondria; Overnutrition; Pediatric Obesity; Rats; Sero | 2023 |
The immediate effect of overnutrition and fluoxetine treatment during the critical period of development on the hippocampus.
Topics: Animals; Female; Fluoxetine; Hippocampus; Mitochondria; Overnutrition; Pediatric Obesity; Rats; Sero | 2023 |
The immediate effect of overnutrition and fluoxetine treatment during the critical period of development on the hippocampus.
Topics: Animals; Female; Fluoxetine; Hippocampus; Mitochondria; Overnutrition; Pediatric Obesity; Rats; Sero | 2023 |
The immediate effect of overnutrition and fluoxetine treatment during the critical period of development on the hippocampus.
Topics: Animals; Female; Fluoxetine; Hippocampus; Mitochondria; Overnutrition; Pediatric Obesity; Rats; Sero | 2023 |